Company: PIII
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001628280-25-015305
Chunk: 160

Company: P3 Health Partners Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 7
Chunk 160
---
089 178,009 Premium deficiency reserve67,368 13,670 Accrued interest12,460 23,648 Current portion of long-term debt65,000 — Liabilities held for sale353 — TOTAL CURRENT LIABILITIES496,415 299,372 Operating lease liability11,339 13,622 Warrant liabilities10,312 1,085 Contingent consideration— 4,907 Long-term debt, net89,824 108,319 Other Long-Term Liabilities26,001 — TOTAL LIABILITIES (1)633,891 427,305 COMMITMENTS AND CONTINGENCIES (Note 13)MEZZANINE EQUITY:Redeemable non-controlling interest73,593 291,532 STOCKHOLDERS’ EQUITY:  Class A common stock, $0.0001 par value; 800,000 shares authorized; 162,870 and 116,588 shares issued and outstanding as of December 31, 2024 and 2023, respectively16 12 Class V common stock, $0.0001 par value; 205,000 shares authorized; 195,957 and 196,569 shares issued and outstanding as of December 31, 2024 and 2023, respectively20 20 Additional paid in capital579,093 509,442 Accumulated deficit (503,193)(367,344)TOTAL STOCKHOLDERS’ EQUITY 75,936 142,130 TOTAL LIABILITIES, MEZZANINE EQUITY, AND STOCKHOLDERS’ EQUITY $783,420 $860,967 

_____________________________________________

(1)The Company’s consolidated balance sheets include the assets and liabilities of its consolidated variable interest entities (“VIEs”). As discussed in Note 20 “Variable Interest Entities,” P3 LLC is itself a VIE. P3 LLC represents substantially all the assets and liabilities of the Company. As a result, the language and amounts below refer only to VIEs held at the P3 LLC level. The consolidated balance sheets include total assets that can be used only to settle obligations of P3 LLC’s consolidated VIEs totaling $9.3 million and $8.6 million as of December 31, 2024 and 2023, respectively, and total liabilities of P3 LLC’s consolidated VIEs